39 related articles for article (PubMed ID: 27496459)
1. Effect of Calcineurin Inhibitors and Mammalian Target of Rapamycin Inhibitors on the Course of COVID-19 in Kidney Transplant Recipients.
Hasbal NB; Turgut D; Gok Oguz E; Ulu S; Gungor O
Ann Transplant; 2021 Mar; 26():e929279. PubMed ID: 33707409
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic Effect of mTOR Inhibition-based Immunosuppressive Therapy on T- and B-cell Subsets After Renal Transplantation.
Wei X; Weber S; Yin D; Allabauer I; Jobst-Schwan T; Wiesener M; Schiffer M; Dudziak D; Lehmann CHK; Woelfle J; Hoerning A
Transplant Direct; 2024 Jul; 10(7):e1666. PubMed ID: 38911271
[TBL] [Abstract][Full Text] [Related]
3. Chances and risks of sodium-glucose cotransporter 2 inhibitors in solid organ transplantation: A review of literatures.
Schwarzenbach M; Bernhard FE; Czerlau C; Sidler D
World J Transplant; 2021 Jul; 11(7):254-262. PubMed ID: 34316450
[TBL] [Abstract][Full Text] [Related]
4. Potential Effects of Immunosuppression on Oxidative Stress and Atherosclerosis in Kidney Transplant Recipients.
Kwiatkowska M; Oldakowska-Jedynak U; Wojtaszek E; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6660846. PubMed ID: 33688391
[TBL] [Abstract][Full Text] [Related]
5. Progression of endothelial dysfunction, atherosclerosis, and arterial stiffness in stable kidney transplant patients: a pilot study.
Junarta J; Hojs N; Ramphul R; Lowe-Jones R; Kaski JC; Banerjee D
BMC Cardiovasc Disord; 2020 Jan; 20(1):6. PubMed ID: 31914943
[TBL] [Abstract][Full Text] [Related]
6. Effect of sirolimus on carotid atherosclerosis in kidney transplant recipients: data derived from a prospective randomized controlled trial.
Silva AL; Fusco DR; Nga HS; Takase HM; Bravin AM; Contti MM; Valiatti MF; de Andrade LGM
Clin Kidney J; 2018 Dec; 11(6):846-852. PubMed ID: 30524720
[TBL] [Abstract][Full Text] [Related]
7. Conversion From Calcineurin to Mammalian Target of Rapamycin Inhibitors in Liver Transplantation: A Meta-Analysis of Randomized Controlled Trials.
Glover TE; Watson CJ; Gibbs P; Bradley JA; Ntzani EE; Kosmoliaptsis V
Transplantation; 2016 Mar; 100(3):621-9. PubMed ID: 26636736
[TBL] [Abstract][Full Text] [Related]
8. Conversion From Calcineurin Inhibitors to Mammalian Target-of-Rapamycin Inhibitors in Heart Transplant Recipients: A Meta-Analysis of Randomized Controlled Trials.
Qiu Y; Wang X; Fan J; Rao Z; Lu Y; Lin T
Transplant Proc; 2015 Dec; 47(10):2952-6. PubMed ID: 26707320
[TBL] [Abstract][Full Text] [Related]
9. Long-term cardiovascular outcome of renal transplant recipients after early conversion to everolimus compared to calcineurin inhibition: results from the randomized controlled MECANO trial.
van Dijk M; van Roon AM; Said MY; Bemelman FJ; Homan van der Heide JJ; de Fijter HW; de Vries APJ; Bakker SJL; Sanders JSF
Transpl Int; 2018 Dec; 31(12):1380-1390. PubMed ID: 30106185
[TBL] [Abstract][Full Text] [Related]
10. The effect of immunosuppressive treatment on arterial stiffness and matrix Gla protein levels in renal transplant recipients.
Gungor O; Kircelli F; Carrero JJ; Hur E; Demirci MS; Asci G; Toz H
Clin Nephrol; 2011 Jun; 75(6):491-6. PubMed ID: 21612751
[TBL] [Abstract][Full Text] [Related]
11. Mammalian Target of Rapamycin Inhibitors Combined With Calcineurin Inhibitors as Initial Immunosuppression in Renal Transplantation: A Meta-analysis.
Montero N; Quero M; Melilli E; Pérez-Sáez MJ; Redondo-Pachón D; Bestard O; Crespo M; Cruzado JM; Pascual J
Transplantation; 2019 Oct; 103(10):2031-2056. PubMed ID: 31343574
[TBL] [Abstract][Full Text] [Related]
12. Impact of late calcineurin inhibitor withdrawal on ambulatory blood pressure and carotid intima media thickness in renal transplant recipients.
Mourer JS; de Koning EJ; van Zwet EW; Mallat MJ; Rabelink TJ; de Fijter JW
Transplantation; 2013 Jul; 96(1):49-57. PubMed ID: 23715049
[TBL] [Abstract][Full Text] [Related]
13. Immunological Results of Long-Term Use of Mammalian Target of Rapamycin (mTOR) Inhibitors and Its Effects on Renal Graft Functions.
Tanrısev M; Ayna Kılıçaslan T; Çolak H; Ersan S; Yılmaz B; Alp A; Tuğmen C; Sevgili BE
Ann Transplant; 2021 Sep; 26():e932434. PubMed ID: 34531361
[TBL] [Abstract][Full Text] [Related]
14. Effect of Immunosuppressive Treatment on Carotid Atherosclerosis in Renal Transplant Recipients.
Szymczak M; Kluz J; Małecki R; Wątorek E; Obremska M; Głuszek M; Klinger M; Boratyńska M
Transplant Proc; 2016 Jun; 48(5):1626-9. PubMed ID: 27496459
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
